OPT-302 combination therapy with ranibizumab for PCV shows VA gains, anatomic improvements in phase 2b trial - Modern Retina

At ARVO 2022, Jason S. Slakter, MD, presents data on the efficacy and safety of OPT-302 when combined with ranibizumab for polypoidal choroidal vasculopathy.

Emily Kaiser, editor of Modern Retina, sits down with Jason S. Slakter, MD, to discuss his ARVO 2022 presentation, Efficacy and Safety of OPT-302 in Combination with Ranibizumab for Polypoidal Choroi… [+383 chars]

full article...